V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280011402 | 280006431 | 1.73 | 95.4 | Palliative (P) | 2015-01-03 | 2015-01-11 | CISPLATIN + ETOPOSIDE | N | N | 280030225 | LIPOSOMAL DOXORUBICIN |
| 280011403 | 280006434 | 1.61 | null | Palliative (P) | null | 2014-12-29 | Cyclophosphamide + Topotecan | 02 | Y | 280030233 | PEMBROLIZUMAB |
| 280011404 | 280006437 | 1.7 | 91 | null | 2018-04-26 | 2018-05-07 | TRASTUZUMAB | Y | N | 280030257 | BUSULFAN + MELPHALAN |
| 280011405 | 280010764 | 1.58 | 65.2 | null | 2018-05-21 | 2018-05-21 | Carboplatin + Pemetrexed | 02 | N | 280030265 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 280011406 | 280009365 | 1.74 | 95.8 | Curative (C) | 2017-05-31 | 2017-07-01 | BCG Intravesical | null | null | 280030282 | IRINOTECAN + VINCRISTINE |
| 280011407 | 280006459 | 1.76 | 90 | Curative (C) | 2016-09-24 | 2018-11-04 | NIVOLUMAB | N | N | 280030300 | IVADO |
| 280011408 | 280006461 | 1.65 | 54.4 | Palliative (P) | null | 2018-02-27 | GEDDIS TRIAL | N | null | 280030304 | ETOPOSIDE |
| 280011409 | 280006463 | null | 56.8 | Palliative (P) | 2018-04-30 | 2018-06-05 | BCG Intravesical | N | N | 280030312 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280011410 | 280006465 | 0 | 78.6 | null | 2018-05-03 | 2018-05-11 | Capecitabine + Oxaliplatin 21day | N | N | 280030329 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 280011411 | 280011783 | null | 49 | Curative (C) | 2016-09-15 | 2017-04-27 | Erlotinib | 2 | N | 280030339 | CREATE TRIAL |
| 280011412 | 280006474 | 1.8 | 93.6 | Palliative (P) | 2017-08-13 | 2017-08-13 | PACLITAXEL + TRASTUZUMAB | 02 | null | 280030360 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 280011413 | 280006479 | 1.75 | 66.8 | Palliative (P) | 2018-11-15 | 2018-11-16 | Carboplatin + Pemetrexed | N | N | 280030373 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 280011414 | 280006486 | 1.61 | 82.8 | Palliative (P) | null | 2018-02-04 | ICE + GCSF | N | N | 280030387 | IFOSFAMIDE + VINCRISTINE |
| 280011415 | 280006499 | 1.5 | 42.3 | Curative (C) | 2018-08-17 | 2018-08-27 | Carbo F | 2 | N | 280030450 | VINORELBINE |
| 280011416 | 280006503 | 1.58 | 62.5 | Not known (9) | 2016-10-01 | 2016-11-02 | Capecitabine + Oxaliplatin 21day | null | N | 280030464 | CAPECITABINE + CARBOPLATIN |
| 280011417 | 280006509 | 1.7 | 78.3 | Adjuvant (A) | 2013-12-02 | 2013-12-02 | BUSULFAN + MELPHALAN | N | N | 280030483 | BCG |
| 280011418 | 280006513 | 1.76 | null | Curative (C) | 2016-10-22 | 2016-12-07 | Erlotinib | Y | N | 280030508 | EVEROLIMUS |
| 280011419 | 280006515 | 1.83 | 85.3 | Palliative (P) | 2017-09-26 | 2017-10-02 | Mitomycin Intravesical | null | null | 280030509 | VIDE |
| 280011420 | 280006519 | null | 55 | Palliative (P) | 2019-05-15 | 2019-05-18 | Cetuximab + FLUOROURACIL | 02 | N | 280030515 | DOCETAXEL |
| 280011421 | 280009397 | 1.81 | 91 | Palliative (P) | 2015-06-13 | 2015-06-13 | Cyclophosphamide PO +Vinorelbine IV | 2 | N | 280030524 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280011422 | 280006523 | null | 18.18 | Palliative (P) | 2016-03-16 | 2016-04-16 | Etoposide IV | null | null | 280030527 | IFOSFAMIDE + VINCRISTINE |
| 280011423 | 280006524 | 1.65 | 3.9 | Curative (C) | 2013-12-12 | 2017-05-22 | CARBOPLATIN + FLUOROURACIL | 02 | N | 280030530 | MITOMYCIN INTRAVESICULAR |
| 280011424 | 280006530 | 1.62 | 59.2 | Disease modification (D) | 2017-07-25 | 2017-09-16 | PCV | N | N | 280030568 | PAZOPANIB |
| 280011425 | 280011462 | 1.61 | 56.7 | Disease modification (D) | 2014-01-16 | 2014-12-30 | Cetuximab + CISPLATIN + FLUOROURACIL | N | N | 280030599 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE |
| 280011426 | 280006540 | null | 50.8 | Curative (C) | 2016-07-23 | 2016-09-27 | Cyclophosphamide + Topotecan | 01 | N | 280030629 | ECX |
| 280011427 | 280006544 | 1.7 | 90 | null | 2014-12-03 | 2014-12-12 | MELPHALAN | N | null | 280030635 | MITOMYCIN INTRAVESICULAR |
| 280011428 | 280006546 | 1.76 | 97.3 | Neo-adjuvant (N) | 2018-11-30 | 2019-01-03 | CARBOPLATIN + FLUOROURACIL | 02 | N | 280030638 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 280011429 | 280006548 | 1.8 | null | Curative (C) | 2015-10-05 | 2015-10-15 | MELPHALAN | N | N | 280030639 | DACTINOMYCIN + VINCRISTINE |
| 280011430 | 280006552 | 1.76 | 62 | Curative (C) | 2016-10-21 | 2016-10-23 | CAPECITABINE + OXALIPLATIN | N | N | 280030660 | CARBO + FLUOROURACIL |
| 280011431 | 280006556 | 1.66 | 81 | Palliative (P) | null | 2017-10-12 | DACTINOMYCIN + CYCLO + VINCRISTINE | 02 | N | 280030686 | VINORELBINE |
| 280011432 | 280006565 | 1.67 | 93 | Palliative (P) | 2019-06-28 | 2019-06-28 | NIVOLUMAB | 02 | N | 280030699 | VINCRISTINE |
| 280011433 | 280006568 | 1.87 | 68.4 | Palliative (P) | 2018-11-19 | 2018-12-21 | BUSULFAN + MELPHALAN | N | N | 280030702 | VIA |
| 280011434 | 280006571 | null | 61.5 | Palliative (P) | 2018-01-21 | 2018-04-20 | CARBOPLATIN + FLUOROURACIL | 02 | N | 280030705 | CHOP R |
| 280011435 | 280006578 | 1.8 | 65.5 | null | 2015-01-06 | 2015-06-20 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 280030712 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280011436 | 280006583 | 1.67 | 92 | Palliative (P) | 2017-12-09 | 2018-01-03 | Liposomal Doxorubicin 50mg/m2 | N | N | 280030724 | DACTINOMYCIN + VINCRISTINE |
| 280011437 | 280006585 | 1.69 | 41.5 | Adjuvant (A) | 2017-10-17 | 2017-10-31 | Methotrexate intrathecal | 2 | N | 280030728 | CETUXIMAB + IRINOTECAN + MDG |
| 280011438 | 280006589 | 1.72 | 92 | Palliative (P) | 2019-04-15 | 2019-04-16 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | 280030742 | LIPOSOMAL DOXORUBICIN |
| 280011439 | 280006590 | 1.66 | 69.5 | Neo-adjuvant (N) | 2014-10-05 | 2017-12-09 | EOX | null | null | 280030761 | UKALL2014 |
| 280011440 | 280006593 | 1.71 | 80.55 | Adjuvant (A) | 2015-07-14 | 2016-03-28 | FLUOROURACIL + MITOMYCIN + RT | N | null | 280030769 | DACTINOMYCIN + CYCLO + VINCRISTINE |
| 280011441 | 280006595 | 1.7 | 53.8 | Palliative (P) | 2016-04-01 | 2016-11-11 | NIVOLUMAB | 2 | N | 280030774 | DACTINOMYCIN + VINCRISTINE |
| 280011442 | 280006599 | 1.61 | 56.8 | Curative (C) | 2017-01-08 | 2017-01-16 | CAPECITABINE + IRINOTECAN | N | N | 280030785 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE |
| 280011443 | 280006600 | 1.67 | null | Palliative (P) | null | 2017-06-27 | PACLITAXEL + TRASTUZUMAB | N | N | 280030786 | CARBOPLATIN + LIPOSOMAL DOX |
| 280011444 | 280006602 | 1.65 | 65.5 | null | 2019-03-14 | 2019-03-14 | Bendamustine+Rituximab(Sub Courses) | null | null | 280030791 | DARS TRIAL |
| 280011445 | 280006604 | 1.55 | 56.8 | Curative (C) | 2014-12-31 | 2016-01-28 | ECX | N | N | 280030812 | VINCRISTINE |
| 280011446 | 280006607 | 1.79 | 72 | Palliative (P) | 2016-11-14 | 2016-11-28 | Cyclophosphamide + Vincristine | null | null | 280030815 | DACTINOMYCIN + VINCRISTINE |
| 280011447 | 280006610 | null | 69.9 | null | null | 2016-01-13 | CARBOPLATIN + FLUOROURACIL | N | N | 280030816 | PAZOPANIB |
| 280011448 | 280006616 | null | 92.3 | Curative (C) | 2014-05-21 | 2014-06-03 | CAPECITABINE + IRINOTECAN | N | N | 280013299 | NIVOLUMAB |
| 280011449 | 280006618 | 1.76 | 63 | Palliative (P) | null | 2019-08-10 | CAPECITABINE + IRINOTECAN | 02 | N | 280016663 | VINORELBINE |
| 280011450 | 280006621 | null | 74.7 | Palliative (P) | 2015-04-19 | 2015-04-19 | Carbo F | null | null | 280018042 | VIDE |
| 280011451 | 280011472 | 1.79 | 85.1 | Palliative (P) | 2015-11-26 | 2015-12-02 | Etoposide oral | 2 | N | 280018423 | BUSULFAN + MELPHALAN |